Cullinan Therapeutics receives FDA orphan drug status for leukemia drug
Go back to Cullinan Therapeutics receives FDA orphan drug status for leukemia drug| Consolidated Gems, Inc. (NASDAQ: CGEM) | Delayed: 16.90 +1.87 (12.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.03 | 52 Week High | $0.19 | |||
| Open | $15.27 | 52 Week Low | $0.03 | |||
| Day High | $17.40 | P/E | N/A | |||
| Day Low | $15.26 | EPS | $0.00 | |||
| Volume | 1,005,422 | |||||
